~~<i id='CBF49043C8'><strike id='CBF49043C8'><tt id='CBF49043C8'><pre id='CBF49043C8'></pre></tt></strike></i>~~

Home» comprehensive» fashion

fashion

author：explore 2025-10-06 13:45:09 Page View：52

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Illinois to ban advertising for guns allegedly marketed to kids and militants
Next article： Dobbs anniversary: the lost opportunity of abortion as health care

focus

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

1:03Russia'sDefenseMinistry'sfootageofjointnavaldrillswithChinaintheBeringSea,sharedonAug.4,2023.Rus

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

2:23FloridaGovernorRonDeSantisattendsabarbecueinRye,NewHampshire,July30,2023.RebaSaldanha/ReutersRiv